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Critically Ill Patients
We read with great interest the paper byMylotte et al. (1) in JACC:
Cardiovascular Interventions, which reports the efﬁcacy of multi-
vessel primary percutaneous coronary intervention (MV-PCI) and
compares it with that of culprit-only PCI in patients with ST-
segment elevation myocardial infarction presenting with cardio-
genic shock and resuscitated cardiac arrest. The investigators
suggested that complete up-front revascularization with MV-PCI
has the potential to improve outcomes in critically ill patients.
However, a few issues regarding the interpretation of their data
come to mind.
The study is limited by an obvious patient selection bias. Because
the study was a retrospective analysis of prospectively collected data,
all decisions regarding the PCI were solely at the discretion of the
treating physician. The lesional and procedural factors such as lesion
difﬁculty (included the infarct-related artery [IRA] and non-IRA),
expected procedure time, and operator’s skill level have the potential
to inﬂuence the results. For example, anatomically, the MV-PCI
group may have included “PCI-favorable” cases, and this may have
led to a better patient outcome compared with that for the culprit-
only PCI group. Obviously, the patients with complex “PCI-unfa-
vorable” lesions have a worse prognosis compared with that of
patients with simple lesions (2). In the present study, the lesion
complexity of the IRA and non-IRA between the 2 groups was not
clear. Adjustment with variables that reﬂect lesion complexity (e.g.,
the prevalence of type-C or chronic total occlusion lesions) might
be helpful (3). Additionally, the differences in the devices that were
used for intervention during the more than 10-year period (1998 to
2010) may have affected the outcomes. These differences may have
occurred because of various factors, including improvements in
guidewire ﬂexibility and the stent delivery system. Itmay be helpful to
determine whether the favorable outcome in the MV-PCI group
compared with that in the culprit-only PCI group was consistent
during the time of the study.We believe that the clariﬁcation of these
2 points would further assist in validating this important study.
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Reply
Reply: Challenges in Retrospective Analysis of PCI
Data in Critically Ill Patients
We thank Dr. Endo and colleagues for their interest in our study (1).
They correctly note that the absence of a pre-determined revascu-
larization strategy in this nonrandomized analysis confers the
potential for patient selection or treatment bias. This implies that
when selecting patients for primary multivessel percutaneous
coronary intervention (MV-PCI), the treating physicians may have
cherry picked “better” cases for more complete revascularization.
Although it is likely that a more complete upfront revascularization
strategy was not performed in some patients due to perceived
futility, clinical experience and prior observational studies suggest
that it is higher-, rather than lower-risk patients that are more likely
to be selected for more complete emergent revascularization (2,3).
In our study, the baseline characteristics among the groups were
well matched, and indeed, complex (left main and bifurcation)
infarct-related artery (IRA) lesions were more common in patients
undergoing MV-PCI than in those undergoing culprit-only PCI
(CO-PCI). Furthermore, non-IRA chronic occlusions were equally
pervasive in both groups. Dr. Endo correctly surmises that
successful primary MV-PCI is determined by both anatomical
complexity and physician experience. These factors should be
considered when determining the appropriateness of primary
MV-PCI.
Dr. Endo and colleagues also suggest that temporal changes in
patient outcome may be expected in studies of extended length such
as ours. We dichotomized the entire patient cohort (N ¼ 266)
according to the era of treatment: Group A: 1998 to 2004; and
Group B: 2004 to 2010. The proportion of patients with multivessel
disease (62.9% vs. 64.2%, p ¼ 0.90) and treated with MV-PCI
(24.5% vs. 25.2%, p ¼ 0.99) was similar. In addition, there was no
difference in the rates of PCI success over time (81.1% vs. 84.6%, p¼
0.52). By contrast, thrombus aspiration (18.3% vs. 61.7%, p <
0.0001) and therapeutic hypothermia (10.5% vs. 24.4%, p ¼ 0.003)
weremore frequently applied in themore recent cohort. Numerically,
6-month survival was higher in the contemporary cohort, though this
was not statistically signiﬁcant (30.8% vs. 39.0%, p ¼ 0.96) due to
small patient numbers. As previously stated, the inherent limitations
